Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  GHK-Cu vs BPC-157: A Simple Research Comparison Guide

GHK-Cu vs BPC-157: A Simple Research Comparison Guide

Jun 11, 2026 4 min Skin & Repair
TL;DR
GHK-Cu is a copper-binding peptide studied mainly for skin repair and anti-aging effects, while BPC-157 is a gut-derived peptide explored for musculoskeletal healing. Both are research-only compounds with no FDA approval for human use. Their dosing ranges, routes of administration, and studied applications differ in important ways worth understanding before you dive into the literature.

What Are These Two Peptides, Anyway?

Peptides are tiny proteins — short chains of amino acids. Your body naturally makes both of these, which is part of why researchers find them interesting.

GHK-Cu stands for glycyl-L-histidyl-L-lysine copper. The "Cu" part just means it binds tightly to copper, a mineral your body already uses. GHK-Cu is found naturally in human blood, but levels drop sharply as we age — from around 200 ng/ml at age 20 down to about 80 ng/ml by age 60.[5] Researchers have studied it for wound healing, collagen production, skin remodeling, and even anti-inflammatory effects.[3] You can explore the full dosing landscape on our GHK-Cu chart page.

BPC-157 stands for Body Protection Compound-157. It's a 15-amino-acid peptide (called a "pentadecapeptide") originally isolated from human gastric juice — yes, stomach fluid.[1] Preclinical studies have focused heavily on tendon, ligament, muscle, and bone repair.[2] See the detailed research numbers on our BPC-157 chart page.

What Does the Research Actually Say?

Here's the honest summary: most evidence for both peptides comes from animal studies, not human clinical trials. That's important context for everything below.

For GHK-Cu, lab and animal studies suggest it can boost collagen and elastin (the proteins that keep skin firm), support nerve and blood vessel growth, and activate genes linked to tissue repair.[3] One review described it as influencing over 4,000 human genes.[3] Researchers have also flagged potential anti-aging signals, including partial reversal of cognitive decline in aging mice.[5]

For BPC-157, the preclinical picture is similarly promising. Animal models show faster healing of tendons, ligaments, and muscles.[2] A 2025 systematic review found 35 preclinical studies and just one clinical study — a small retrospective report where 7 of 12 patients with chronic knee pain reported relief lasting more than six months after an intraarticular injection.[4] Researchers believe BPC-157 works partly by boosting growth hormone receptor expression and reducing inflammatory signaling.[4]

One key safety note: BPC-157 was temporarily banned by the World Anti-Doping Agency in 2022, though it is no longer on their prohibited list.[1] Neither peptide is FDA-approved for medical use in humans.[6]

Quick Comparison: GHK-Cu vs BPC-157

  • Origin: GHK-Cu is found in blood plasma; BPC-157 is derived from gastric juice.[3][1]
  • Primary research focus: GHK-Cu → skin, collagen, anti-aging; BPC-157 → tendons, ligaments, muscles, bone.[5][2]
  • Typical research routes: GHK-Cu is often studied topically or via injection; BPC-157 research uses subcutaneous and oral routes in animals.[3][4]
  • Research dosing range: BPC-157 animal studies commonly use roughly 10 µg/kg to 10 mg/kg depending on the model and injury type; GHK-Cu topical concentrations in studies vary widely by formulation.[2][3]
  • Human trial data: Both are very limited — one small human study for BPC-157; preliminary human observations for GHK-Cu.[4][5]
  • Regulatory status: Neither is FDA-approved; BPC-157 has had sports-ban history.[1][6]

How Research Dosing Differs

This is where the charts really matter. Dosing in animal research does not translate directly to humans, and comparing the two peptides side-by-side on a per-weight basis isn't straightforward because they've been studied through different routes for different outcomes.

BPC-157 has a short half-life — under 30 minutes in the bloodstream — and is cleared by the kidneys.[4] That affects how researchers design dosing schedules. GHK-Cu, on the other hand, has been studied both systemically and topically, and its copper-chelating nature means formulation chemistry plays a big role in how much actually reaches target tissue.[3]

A narrative review published in 2025 highlighted that unregulated manufacturing of BPC-157 raises contamination concerns, and there is still no clinical safety dataset for humans.[6] Similarly, GHK-Cu research, while extensive in cell and animal models, still needs robust human trials to confirm dosing windows.[5]

If you want to compare published research doses side by side, plug the numbers into our calculator to see how animal doses scale across body weights — useful for understanding what researchers are actually testing.

How to Choose What to Read About

Ask yourself what tissue or outcome you're curious about. Interested in skin aging, wound repair, or collagen? Start with GHK-Cu. Curious about tendon recovery, ligament healing, or sports injuries? The BPC-157 literature is deeper on those topics.[2][4]

Either way, go in knowing that exciting preclinical results don't always survive human trials. The research is genuinely interesting — and genuinely incomplete.

Sources

  1. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. — Pharmaceuticals (Basel, Switzerland), 2025. PMID 40005999.
  2. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. — Cell and tissue research, 2019. PMID 30915550.
  3. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. — International journal of molecular sciences, 2018. PMID 29986520.
  4. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. — HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025. PMID 40756949.
  5. The potential of GHK as an anti-aging peptide. — Aging pathobiology and therapeutics, 2020. PMID 35083444.
  6. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. — Current reviews in musculoskeletal medicine, 2025. PMID 40789979.
See the dosage chart — GHK-Cu
A copper-binding tripeptide researched for skin remodeling and wound repair.
GHK-Cu

FAQ

Is GHK-Cu or BPC-157 approved for human use?
Neither peptide is approved by the FDA or equivalent global regulatory bodies for medical use in humans. Both are classified as research compounds. BPC-157 was also temporarily listed as banned by the World Anti-Doping Agency in 2022, though it is no longer on their current prohibited list. Always check current regulations in your region before reading about these compounds in an applied context.[1][6]
What is the main difference in what each peptide has been studied for?
GHK-Cu research focuses heavily on skin repair, collagen production, anti-aging effects, and gene expression changes. BPC-157 research is concentrated on musculoskeletal healing — tendons, ligaments, muscles, and bone — as well as gut protection. Both have broad preclinical profiles, but their primary studied applications point in different directions depending on the tissue type you're reading about.[3][2]
How much human clinical evidence exists for either peptide?
Human clinical data is very limited for both. For BPC-157, a 2025 systematic review found only one clinical study among 36 total papers — a small retrospective report on knee pain. For GHK-Cu, preliminary observations in aging studies exist but large-scale human trials are still lacking. Most knowledge comes from cell cultures and animal models, which don't always predict human outcomes.[4][5]
Can I use the dosing charts to figure out a personal dose?
The charts and calculator on this site are strictly for educational and research-reading purposes. They help you understand what doses scientists used in published studies and how those figures scale across body weights in animal models. They are not medical advice, and no dosing information here should be interpreted as a recommendation for personal use. Always consult a qualified healthcare professional for any health-related decisions.[4][6]
For research and educational use only. Not medical advice.